NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported exceptional financial results for fourth-quarter and full-year 2022 and provided 2023 financial guidance (4). The fourth-quarter 2022 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results